TIPS
1. Download the IT Orange APP to track investment and financing events in the primary market at home and abroad in real time. 2. Please indicate that the source is from IT orange (itjuzi521), and the infringement must be investigated. 3. Establish a long-term release cooperation of "Investment Express", please send an email to [email protected].
July 30, 2024
IT 桔子(itjuzi521)
Includes 20 investment/acquisition/IPO queue events
Wofei Changkong completed the B+ round of financing, and the investor was Chengdu Advanced Manufacturing Industry Investment.
Wofei Changkong is a brand of Geely Holding Group, which is committed to the R&D and commercial operation of global low-altitude intelligent transportation aircraft. Focusing on the development of low-altitude travel and vehicle-mounted flight business, Wofei Changkong has launched low-altitude travel products such as VoloCity light flying cars and AE200 series wide-body flying cars.
Jushi New Energy has received hundreds of millions of yuan in strategic financing, and investors include Xiaomi.
Jushi New Energy is a manufacturer of battery trays for new energy vehicles, which has opened up the market for new energy vehicle battery trays that replace aluminum with steel.
Domestic investment events
1. Juhai Hengchuang received angel round investment
Juhai Hengchuang is a medical device manufacturer, mainly engaged in the sales of drug testing instruments; Manufacture of drug testing instruments. Recently, Juhai Hengchuang completed an angel round of financing of 30 million yuan. This round of financing was led by Hangzhou Taiyu Investment Consulting Co., Ltd., followed by Jiaxing Deshi Jianchuang Equity Investment Partnership (Limited Partnership), and Yiran Capital served as the exclusive financial advisor.
2. BRD completed a Series B financing of RMB 250 million
BRD is a low-cost genotyping solution provider, focusing on the R&D and service of animal and plant molecular breeding technology, with GenoPlexs and GenoBaits two independent intellectual property rights of targeted gene capture and sequencing technology system, providing customers with excellent capture efficiency, flexible marker types and capture types, and low-cost customized services. Recently, BRD completed a Series B financing of 250 million yuan, led by 1.8 Agricultural Science and Technology Group, followed by Huajian Function, Guofa Venture Capital, Qingchi Capital, Jiuyi Investment, Daotong Investment and Haochen Capital. FA is Kaicheng Capital.
3. Hengdao Technology completed Series B financing, with exclusive investment from Yuanjing
Hengdao Technology Co., Ltd. is a limited liability company specializing in the production of injection mold hot runner systems, focusing on the research and development of hot runner technology, and committed to providing high-quality products and value-added pre-sales and after-sales services. Recently, Hengdao Technology completed more than 50 million yuan in Series B financing, which was exclusively invested by Yuanjing Capital. After the completion of this round of financing, Hengdao Technology will increase the research and development of hot runner technology, further strengthen the construction of production capacity and gradually expand the scale of hot runner business, and consolidate the leading position in the industry.
4. Ze'an Biopharma completed Series A financing
Based on reverse translational science and emerging tumor microenvironment biology, Zean Biotech is committed to developing next-generation immunotherapies that can not only overcome drug resistance and recurrence, but also enhance anti-tumor immunity. Recently, Ze'an Biotech completed a round of financing, raising more than $20 million. This round of financing was led by Longpan Investment, with Hillhouse Venture Capital participating in the investment, and received additional investment from old shareholders such as Qiming Venture Capital, Xianfeng Qiyun, and Shunwei Capital.
5. Eene shares are listed on the New Third Board for public transfer
Committed to the professional field of corrosion and protection, Yuene Co., Ltd. is a national high-tech enterprise integrating R&D, production and service, and its main business includes three parts: (1) the production of corrosion protection materials and equipment, special functional materials, and high-performance DSA anode materials; (2) Design, consulting and engineering construction of corrosion and protection solutions; (3) Corrosion supervision, testing and information operation and maintenance services. It is mainly used in marine equipment and infrastructure, petroleum, petrochemical and energy, as well as urban infrastructure such as water supply, heating, gas supply, and bridges. Recently, the listing application of Zhejiang Edenene Corrosion Control Co., Ltd. (stock abbreviation: Edenene shares) was approved and will be listed on July 30, 2024.
6. Xicheng Technology completed a new round of financing
Xicheng Technology is a professional automotive electronic and electrical parts enterprise. Equipped with a laboratory that meets industry standards, it has mass-produced more than 20 varieties of products in six series, and can directly carry out synchronous design, development and verification with various OEMs. Recently, Xicheng Technology completed a new round of financing, and the investor is Industrial Securities Capital.
7. Zhisheng Education received 20 million yuan in financing
Zhisheng Education is a service provider for improving the skills of the high school entrance examination, and is committed to helping students break through the difficulties of the high school entrance examination and realize their academic dreams. With its unique teaching concept, professional teaching and research team, and innovative AI technology, its core product, Huikaowang, has successfully helped more than 20,000 students achieve significant scores in the high school entrance examination. Recently, Zhisheng Education received 20 million yuan of financing from Zhejiang Zhonglong Holding Group, led by Zhonglong Holdings.
8. Zhengli New Energy completed RMB 1 billion Series B financing
Zhengli New Energy is a new energy power battery manufacturer, mainly engaged in the research and development, production, sales and technology transfer of new energy lithium-ion batteries, energy storage batteries and charging stations, which are widely used in electric vehicles, energy storage and communication base stations. Recently, Zhengli New Energy completed a Series B financing of 1 billion yuan, and the investors are Xinzhongyuan Venture Capital. The proceeds will be used for the construction of the first and second phases of the new production plant in Changshu.
Foreign investment events
1. Hive Health获得650万美元Pre-A轮融资
Hive Health is a full-stack digital health insurance provider that aims to provide HMO health plans to SMEs and start-ups. HMO is a managed care model that provides a comprehensive package of medical services to voluntary participants in the region, primarily through consultation with specific doctors, hospitals, and clinics. Hive Health currently has nearly 1,700 clinics and more than 60,000 physicians, covering outpatient, inpatient, emergency and dental care departments. Hive Health has announced that it has raised $6.5 million in its Pre-A round of funding. The financing was provided by Gentree Fund, BEENEXT, Y Combinator, The Graduate Syndicate, Amasia, Oak Drive Ventures, and select angel investors.
2. Rillet received a $13.5 million strategic investment
Rillet is an automated ERP vendor built for the workflows of accounting and finance teams at high-growth companies, including automated invoicing, revenue recognition, advance payments, and investor reporting. Recently, Rillet raised $13.5 million. Backers include First Round Capital and Creandum, and individual investors include Chad Byers (Susa Ventures), Kevin Hartz (founder of Eventbrite and Xoom), former chief accounting officers of Facebook and Stripe, and financial director of Ramp.
3. osapiens raises $120 million in Series B financing
osapiens is an ESG software solutions provider that develops software-as-a-service solutions that help companies across a wide range of industries implement ESG requirements quickly, automatically, and securely. At the heart of the company is the osapiens HUB, an AI-based cloud platform that creates compliance and transparency along the value chain. It allows companies to address all ESG challenges to identify risks, implement reporting requirements such as CSRD, EUDR and CSDDD, and make their operational processes more sustainable in the long term. Recently, osapiens received a $120 million Series B funding round with investment from Goldman Sachs Alternatives.
4. Osheru raised $4.7 million in seed round
Osheru, a developer of blepharoplasty equipment, has developed a new medical device, Ziplyft, that significantly simplifies and improves the traditional blepharoplasty process. Includes long recovery time and risk of complications such as wound dehiscence, asymmetry, and reduces recovery time and enhances aesthetic results through its proprietary design. Recently, Osheru raised $4.7 million in seed rounds, led by Phil Knight, with participation from ONAMI and SOPHINCAP.
5. Protembis receives a strategic investment of 20 million euros
Protembis, a medical device developer that minimizes the risk of particle transfer to the brain during interventional cardiac surgery, is developing an innovative brain protection system that incorporates the ProtEmbo® system into every interventional procedure with a risk of nerve damage, thereby radically improving surgical safety. Recently, Protemb received 20 million euros from the EIB European Investment Bank.
6. SPEAR BIO raises $45 million in Series A financing
Spear Bio is a next-generation proteomics and immunodiagnostic technology developer, and the core technology of Spear Bio is derived from SPEAR, a next-generation ultra-sensitive no-elution immunodetection technology platform developed by Professor Yin Peng's laboratory. Through the unique probe design, the technology platform realizes the dual verification of "protein-protein interaction" and the automatic conversion of protein information to nucleic acid sequence, which can greatly improve the signal-to-noise ratio and specificity of protein detection. Moreover, compared with single-molecule technology, the SPEAR technology platform is more simple and easy to use, which can greatly reduce the threshold for the use of ultra-sensitive protein detection technology. Recently, SPEAR BIO received $45 million in Series A financing from Foresite Capital, Bio-Techne, Maverick Ventures, Yonjin Capital, and CDH Investments.
7. Axle Automation raises $2.5 million in seed round
Axle Automation, a provider of AI solutions for compliance teams focused on leveraging generative AI to automate and enhance AML compliance processes, is focused on streamlining operations, such as enhancing due diligence, thereby enabling financial institutions to effectively scale their compliance efforts, with the aim of reducing fraud, compliance risks, and operational costs while increasing revenue by automating these traditionally manual and inefficient processes. Axle Automation announced the successful closing of its seed round. The round was led by Diagram Ventures, with participation from Mistral Ventures, Uphonest Capital, StreamingFast and other strategic angel investors.
8. Figma raises $700 million Series E+ financing
Figma is an online design collaboration tool platform in United States that provides users with features such as sketch import, pixel preview, layout grid, cropping, fill mode, etc., users do not have to upload or download files, team collaboration members can see changes and updates in real time, and can discuss in the messaging tool. Recently, Figma received a new round of financing. Investors including Coatue, Alkeon Capital Management and General Catalyst Partners have invested in Figma at a valuation of US$12.5 billion (equivalent to 91 billion yuan). Cougue has added to the stake for its existing shareholders, and Sequoia, A16Z, Kleiner Perkins and Durable Capital Partners have also continued to follow, as well as hedge funds SurgoCap Partners, Atlassian Corp., Fidelity, Franklin Venture Partners, Iconiq, Thrive Capital and others. It is reported that Apple executive Eddy Cue has also made an investment.
IPO queue
1. Rumors of the listing of Sino French Water
The core business of Sino French Water covers four major areas: water supply, sewage treatment, municipal engineering construction and smart water affairs, of which the water supply has 3 surface water plants and a complete customer service system, with a daily water supply capacity of 875,000 cubic meters and a population of about 1.8 million. There are 6 sewage treatment plants with a daily treatment capacity of 255,000 cubic meters, and 3 sewage treatment plants with a daily treatment capacity of 55,000 cubic meters. It has the third-level qualification of general contracting of municipal public works construction, and can undertake water supply and drainage projects within the scope of qualification. With the ability of intelligent water technology, we provide intelligent water solutions including operation management system, online hydraulic model, production and sales gap analysis system, project management system, etc. Today's Sino-French Water listing rumors.
2. Tongyuankang Pharmaceutical submits a prospectus
Tongyuankang Pharmaceutical is an innovative drug R&D company, which has established a small molecule drug design and screening platform, a deuterated drug R&D technology platform, and a macromolecule immunotherapy platform focusing on targeted therapy, and is committed to the research and development of cancer treatment and anti-cancer drugs. Today, Tongyuankang Pharmaceutical submitted a prospectus.
* Non-advertising
![Skills are not as good as others? Why is it that the US space vehicle can be reused 100 times, and China will scrap it after using it once?[fig]](data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACwAAAAAAQABAAACAkQBADs=)